With all of this news about HRT causing breast cancer these days, one question comes to mind: why wasn't this reported before? And was HRT adequately tested for safety in long-term human trials in the first place? Probably not, and yet it has been prescribed for decades to millions of women around the world. That's bad medicine.
Doctors have halted another hormone replacement therapy study after
they found that women involved in the research were facing an
"unacceptably high risk" of breast cancer.
The trial into whether women who had been treated for breast cancer
could safely be given HRT has been stopped for ethical reasons because
scientists discovered that the menopause treatment was causing new
tumours to appear in some patients.
Previously, some were offered the option of HRT, but scientists were
worried that the tablets could raise the risk of the disease recurring.
Of 174 former breast cancer sufferers assigned to HRT, 26 reported a
recurrence or a new case of the cancer while seven women who received
therapy other than HRT for menopausal symptoms developed the disease
again.